Nasdaq: ORMP
Oramed Pharmaceuticals insiders
The officers, directors and 10% owners of Oramed Pharmaceuticals Inc. who hold the most stock, valued at the live ORMP price.
$3.69
ORMP today −$200K (−5.14%)
Market closed. Prices as of Nov 19, 4:04 PM ET
- Ranked insiders
- 6
- Their ORMP stock
- $48.9M
- Market value
- $160M
- Held by ranked insiders
- 30.5%
Insiders by value of ORMP holdings
SEC ownership page| # | Insider | Role | Shares | Value | Of company | Overall rank |
|---|---|---|---|---|---|---|
| 1 | Nadav Kidron | President and CEO | 5,457,505 | $20.1M | 12.6% | 5151st |
| 2 | Miriam Kidron | Chief Scientific Officer | 2,149,554 | $7.9M | 4.94% | 10419th |
| 3 | Benjamin Shapiro | Director | 2,097,050 | $7.7M | 4.82% | 10621st |
| 4 | Joshua Hexter | COO & CBO | 1,927,130 | $7.1M | 4.43% | 11271st |
| 5 | Avraham Gabay | Chief Financial Officer | 1,460,076 | $5.4M | 3.36% | 13671st |
| 6 | Yadin Rozov | Director | 155,320 | $573K | 0.36% | 4300th |
Only insiders worth at least $5 million in listed stock are ranked. Holdings come from each insider's latest Form 3, 4 or 5 for Oramed Pharmaceuticals; see each profile for the filing.